<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03433911</url>
  </required_header>
  <id_info>
    <org_study_id>CP-100-007</org_study_id>
    <nct_id>NCT03433911</nct_id>
  </id_info>
  <brief_title>FemBloc® Contraception Pivotal Trial</brief_title>
  <acronym>BLOC</acronym>
  <official_title>BLOC: Prospective Multi-Center Office Based Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Femasys Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Femasys Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multi-center, international, non-randomized, two-arm study of subjects
      undergoing either FemBloc or laparoscopic bilateral tubal sterilization (Control). The
      FemBloc group total study duration will be approximately 65 months. The laparoscopic tubal
      sterilization (Control) group total study duration will be approximately 62 months.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 30, 2018</start_date>
  <completion_date type="Anticipated">March 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Confirmed pregnancy rate for subjects told to rely on FemBloc for birth control</measure>
    <time_frame>1 year from being told to rely</time_frame>
    <description>Confirmed pregnancy rate for subjects told to rely on FemBloc for birth control</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reliance rate</measure>
    <time_frame>Within 1 year</time_frame>
    <description>Number of subjects told to rely divided by number of qualified subjects</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Long-term pregnancy rate for subjects told to rely on FemBloc for birth control</measure>
    <time_frame>2-5 years</time_frame>
    <description>Long-term pregnancy rate for subjects told to rely on FemBloc for birth control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of short-term and long-term adverse events in each arm</measure>
    <time_frame>1-5 years</time_frame>
    <description>Safety: Incidence of short-term and long-term adverse events in each arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction/comfort assessed by questionnaire</measure>
    <time_frame>1-5 years</time_frame>
    <description>Satisfaction/comfort assessed by subject questionnaire at various timepoints</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">975</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>FemBloc</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational device and procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic bilateral tubal sterilization</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FemBloc</intervention_name>
    <description>Treatment with FemBloc for women who desire permanent birth control (female sterilization)</description>
    <arm_group_label>FemBloc</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic bilateral tubal sterilization</intervention_name>
    <description>Laparoscopic bilateral tubal sterilization for women who desire permanent birth control (female sterilization)</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female, 21 - 45 years of age desiring permanent birth control

          -  Sexually active with male partner

          -  For FemBloc Arm:

               -  Regular menstrual cycle for last 3 months or on hormonal contraceptives

          -  For Control Arm:

               -  Undergoing planned laparoscopic bilateral tubal sterilization

        Exclusion Criteria:

          -  Uncertainty about the desire to end fertility

          -  Known or suspected pregnancy

          -  Prior tubal surgery, including sterilization attempt

          -  Prior endometrial ablation

          -  Presence, suspicion, or previous history of gynecologic malignancy

          -  Abnormal uterine bleeding requiring evaluation or treatment

          -  Scheduled to undergo concomitant intrauterine procedures at the time of procedure(s)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sponsor</last_name>
    <role>Study Director</role>
    <affiliation>Medical Affairs &amp; Clinical Development</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Study Director</last_name>
    <phone>770-500-3910</phone>
    <phone_ext>146</phone_ext>
    <email>Studysupport@femasys.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Visions Clinical Research</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center for Clinical Research</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Virtus Research Consultants, LLC</name>
      <address>
        <city>Lake Worth</city>
        <state>Florida</state>
        <zip>33414</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Women's Health Associates</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rosemark™ Clinical Research</name>
      <address>
        <city>Idaho Falls</city>
        <state>Idaho</state>
        <zip>83404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wake Research Associates</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Amy Brenner MD &amp; Associates, LLC®</name>
      <address>
        <city>Mason</city>
        <state>Ohio</state>
        <zip>45040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chattanooga Medical Research, LLC</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2018</study_first_submitted>
  <study_first_submitted_qc>February 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2018</study_first_posted>
  <last_update_submitted>May 23, 2018</last_update_submitted>
  <last_update_submitted_qc>May 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Permanent contraception</keyword>
  <keyword>Birth control</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

